Showing results (61-70 of 160) with videos related to
Sort By:
Pageof 16
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1979
Arrest of cultured cells in the G1 phase of the cell cycle by indomethacinB M Bayer, H S Kruth, M Vaughan, et al.The Journal of Clinical Investigation|July 1, 1985
Binding of diamine oxidase activity to rat and guinea pig microvascular endothelial cells. Comparisons with lipoprotein lipase bindingA Robinson-White, S B Baylin, T Olivecrona, et al.The Journal of Biological Chemistry|July 25, 1989
Antigen-induced secretion of histamine and the phosphorylation of myosin by protein kinase C in rat basophilic leukemia cellsR I Ludowyke, I Peleg, M A Beaven, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1986
Phorbol myristate acetate inhibits anti-IgM-mediated signaling in resting B cellsJ Mizuguchi, M A Beaven, J H Li, et al.Biochemical Pharmacology|April 1, 1982
Histamine synthesis in intact and disrupted rat mast cellsM A Beaven, N B Roderick, R E Shaff, et al.Molecular Pharmacology|October 1, 1991
GTP-binding protein G alpha Z: its down-regulation by dexamethasone and its credentials as a mediator of antigen-induced responses in RBL-2H3 cellsM Hide, H Ali, S R Price, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1996
Enhancement of TNF-alpha synthesis by overexpression of G alpha z in a mast cell lineR A Baumgartner, N Hirasawa, K Ozawa, et al.The Journal of Biological Chemistry|October 5, 1988
Formation of inositol 1,4,5-trisphosphate and inositol 1,3,4-trisphosphate from inositol 1,3,4,5-tetrakisphosphate and their pathways of degradation in RBL-2H3 cellsJ R Cunha-Melo, N M Dean, H Ali, et al.Klinische Wochenschrift|September 1, 1982
The demonstration of histamine release in clinical conditions: a review of past and present assay proceduresM A Beaven, A Robinson-White, N B Roderick, et al.The Journal of Clinical Investigation|August 1, 1973
Response of plasma histaminase activity to small doses of heparin in normal subjects and patients with hyperlipoproteinemiaS B Baylin, M A Beaven, R M Krauss, et al.Pageof 16